Filter posts

Double Jeopardy at the PTO Threatens Healthcare Innovation

There has been no shortage of commentary related to the efforts of Allergan to shield …

Strong Public Policy is the Bedrock of Biotech Economic Growth

As noted in the recently-released 2017 BIO publication Bioscience Innovation in the States: Job Creation …

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …

Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency

Deborah Goldberg’s op-ed to The Sacramento Bee recounts her three-year battle with colon cancer. She …

Group of Inventors Burn Their Patents in Protest

As reported last week by IP Watchdog, the United States Patent and Trademark Office (PTO) …

Weak Patent Law Endangers Healthcare Innovation

Last week The Wall Street Journal published a fascinating expose that pulled back the curtain …

Colorado Looks to Grow Biotech Industry

Colorado BioScience Association today launched Breakthrough Profiles, a social media campaign in partnership with Colorado’s …

BIO Expands Cooperation with China-Based Pharma Group

Earlier this week BIO signed of a Memorandum of Understanding for Cooperation with the Pharmaceutical Association …

City of South San Francisco Recognizes Contributions to Biotech Industry Growth

BIO’s Pete Pellerito yesterday received the City of South San Francisco’s first ever special recognition …